Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
The sub-typing of lung cancer and squamous cell carcinoma
Dr Martin Edelman - University of Maryland Medical Center, USA
The sub-typing of lung cancer and squamous cell carcinoma ( Dr Martin Edelman - University of Maryland Medical Center, USA )
15 May 2013
Treatment of non-small cell lung cancer and adenocarcinoma
Dr Keith Kerr – University of Aberdeen, UK
Treatment of non-small cell lung cancer and adenocarcinoma ( Dr Keith Kerr – University of Aberdeen, UK )
15 May 2013
Treating adenocarcinoma with bevacizumab
Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland
Treating adenocarcinoma with bevacizumab ( Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland )
15 May 2013
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2...
Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013
Genetic alterations in postmenopausal women with hormone receptor-positive...
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013
Implementation of individualised treatment and the WINTHER trial
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Implementation of individualised treatment and the WINTHER trial ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Importance of personalised medicine and the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Importance of personalised medicine and the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Achievements of the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Achievements of the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Goal of the 2013 WIN Symposium
Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013
Approaches to treatment of brain metastasis
Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy
Approaches to treatment of brain metastasis ( Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy )
23 Apr 2013
Myc inhibition in pre-clinical mouse models
Dr Laura Soucek - Vall d'Hebron Institute of Oncology
Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )
22 Apr 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation